Product Code: GVR-4-68038-141-2
Blood Warmers Market Growth & Trends
The global blood warmer market size is expected to reach USD 2.01 billion by 2030, registering a CAGR of 8.47%, according to a new report by Grand View Research, Inc. Rising incidences of road accidents, mishaps and other injuries, rising burden of hypothermia cases along with growing demand for blood warmers from ambulatory services and military/defense sectors, operating in extreme temperature environments are expected to propel the market demand for such devices over the forecast period.
Over the recent past, the COVID-19 pandemic has been associated with surges in hospitalization globally, this is expected to have a positive impact on the market. The demand for infusion therapy surged significantly during this period. This is one of the key factors driving up demand for blood warmer devices, which are used to raise fluids to body temperature, speed up patient recovery, and reduce the danger of transfusion shock.
Moreover, various manufacturers are adopting strategies such as mergers and acquisitions, partnerships, and product launches to strengthen their foothold in the market. For instance, in December 2020, Danish MedTech Company MEQU released the Power Pack, a new battery for its M Warmer System, a compact blood and IV fluid-warming systems. The system is commonly used in prehospital emergency settings. Such product launches are expected to propel the market over the forecast period.
Blood Warmers Market Report Highlights
- Based on product, non-portable blood warmers segment held the largest market share of 55.26% in 2022. The increasing rate of hospitalization rising aging population, and improving financing for healthcare infrastructure in developing economies are all likely to propel this segment growth
- In end-use scope, the hospital-based segment dominated the market with a share of 65.29% in 2022. Blood warmers are commonly employed in hospitals because they can heat a larger volume of blood or IV solutions while also being more affordable & easier to maintain
- North America dominated the blood warmers market and accounted for the highest revenue share of 40.76% in 2022, owing to the increase in the number of surgical procedures/hospital visits, presence of well-established healthcare infrastructure, and favorable reimbursement in the healthcare sector
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Product
- 1.1.2 Application
- 1.1.3 End-Use
- 1.1.4 Regional Scope
- 1.1.5 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Volume Price Analysis (Model 2)
- 1.6.2.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 Blood Warmers Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 User Perspective Analysis
- 3.3.1 Consumer Behavior Analysis
- 3.3.2 Market Influencer Analysis
- 3.4 List Of Key End-Users
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Increasing Number Of Surgeries And Trauma Cases
- 3.5.1.2 Growing Demand For Blood Warmers From Ambulatory Services And Military/Defense Sectors
- 3.5.1.3 Increasing Demand For Portable Blood/Iv Fluid Warmers
- 3.5.2 Market Restraints Analysis
- 3.5.2.1 Low Market Penetration In Emerging Economies Due To High Cost
- 3.5.2.2 Product Recalls
- 3.5.3 Market Opportunities Analysis
- 3.5.3.1 Increasing R&D Of Innovative Products
- 3.6 Blood Warmers: Market Analysis Tools
- 3.6.1 Industry Analysis - Porter's
- 3.6.2 Swot Analysis, By Pest
- 3.7 Impact Of Covid-19 On Market & Post Pandemic Recovery Analysis
Chapter 4 Blood Warmers Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1 Definition And Scope
- 4.2 Product Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 Global Blood Warmers Market, By Product, 2018 To 2030
- 4.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
- 4.4.1 Portable Blood Warmers
- 4.4.1.1 Portable Blood Warmers Market, 2018 - 2030 (USD Million)
- 4.4.2 Non-Portable Blood Warmers
- 4.4.2.1 Non-Portable Blood Warmers Market, 2018 - 2030 (USD Million)
Chapter 5 Blood Warmers Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 5.1 Definition And Scope
- 5.2 Application Market Share Analysis, 2022 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Blood Warmers Market, By Application, 2018 To 2030
- 5.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
- 5.5.1 Surgery
- 5.5.1.1 Surgery Market, 2018 - 2030 (USD Million)
- 5.5.2 Acute Care
- 5.5.2.1 Acute Care Market, 2018 - 2030 (USD Million)
- 5.5.3 New Born Care
- 5.5.3.1 New Born Care Market, 2018 - 2030 (USD Million)
- 5.5.4 Homecare
- 5.5.4.1 Homecare Market, 2018 - 2030 (USD Million)
- 5.5.5 Others
- 5.5.5.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Blood Warmers Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)
- 6.1 Definition And Scope
- 6.2 End-Use Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Blood Warmers Market, By End-Use, 2018 To 2030
- 6.5 Market Size & Forecasts And Trend Analysis, 2018 To 2030
- 6.5.1 Hospitals/Clinic
- 6.5.1.1 Hospitals/Clinic Market, 2018 - 2030 (USD Million)
- 6.5.2 Ambulatory Services
- 6.5.2.1 Ambulatory Services Market, 2018 - 2030 (USD Million)
- 6.5.3 Defense Forces
- 6.5.3.1 Defense Forces Market, 2018 - 2030 (USD Million)
- 6.5.4 Rescue Forces
- 6.5.4.1 Rescue Forces Market, 2018 - 2030 (USD Million)
Chapter 7 Blood Warmers Market: Regional Market Analysis, By Product, By End-Use 2018 - 2030 (USD Million)
- 7.1 Definition & Scope
- 7.2 Regional Market Share Analysis, 2022 & 2030
- 7.3 Regional Market Dashboard
- 7.4 Regional Market Snapshot
- 7.5 Market Size, & Forecasts, And Trend Analysis, 2022 To 2030
- 7.6 North America
- 7.6.1 North America Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.6.2 U.S.
- 7.6.2.1 U.S. Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.6.3 Canada
- 7.6.3.1 Canada Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7 Europe
- 7.7.1 Europe Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.2 Uk
- 7.7.2.1 Uk Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.3 Germany
- 7.7.3.1 Germany Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.4 France
- 7.7.4.1 France Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.5 Italy
- 7.7.5.1 Italy Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.6 Spain
- 7.7.7.1 Spain Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.8 Asia Pacific
- 7.7.1 Asia Pacific Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.2 Japan
- 7.7.2.1 Japan Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.3 China
- 7.7.3.1 China (Mainland) Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.4 India
- 7.7.4.1 India Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.5 South Korea
- 7.7.5.1 South Korea Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.7.6 Australia
- 7.7.7.1 Australia Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.9 Latin America
- 7.9.1 Latin America Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.9.2 Brazil
- 7.9.2.1 Brazil Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.9.3 Mexico
- 7.9.3.1 Mexico Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.9.4 Argentina
- 7.9.4.1 Argentina Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.9.5 Colombia
- 7.9.5.1 Colombia Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.10 MEA
- 7.10.1 MEA Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.10.2 South Africa
- 7.10.2.1 South Africa Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.10.3 Saudi Arabia
- 7.10.3.1 Saudi Arabia Blood Warmers Market, 2018 - 2030 (USD Million)
- 7.10.4 UAE
- 7.10.4.1 UAE Market, 2018 - 2030 (USD Million)
Chapter 8 Blood Warmers Market - Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, By Key Market Participants
- 8.2 Company Categorization
- 8.2.1 Innovators
- 8.2.2 Market Leaders
- 8.3 Company Profiles
- 8.3.1 Stryker Corporation
- 8.3.1.1 Company Overview
- 8.3.1.2 Financial Performance
- 8.3.1.3 Product Benchmarking
- 8.3.1.4 Strategic Initiatives
- 8.3.2 Baxter International
- 8.3.2.1 Company Overview
- 8.3.2.2 Financial Performance
- 8.3.2.3 Product Benchmarking
- 8.3.2.4 Strategic Initiatives
- 8.3.3 Gentherm Medical
- 8.3.3.1 Company Overview
- 8.3.3.2 Financial Performance
- 8.3.3.3 Product Benchmarking
- 8.3.3.4 Strategic Initiatives
- 8.3.4 Belmont Medical
- 8.3.4.1 Company Overview
- 8.3.4.2 Financial Performance
- 8.3.4.3 Product Benchmarking
- 8.3.4.4 Strategic Initiatives
- 8.3.5 3M
- 8.3.5.1 Company Overview
- 8.3.5.2 Financial Performance
- 8.3.5.3 Product Benchmarking
- 8.3.5.4 Strategic Initiatives
- 8.3.6 Icu Medical
- 8.3.6.1 Company Overview
- 8.3.6.2 Financial Performance
- 8.3.6.3 Product Benchmarking
- 8.3.6.4 Strategic Initiatives
- 8.3.7 Vyaire Medical, Inc.
- 8.3.7.1 Company Overview
- 8.3.7.2 Financial Performance
- 8.3.7.3 Product Benchmarking
- 8.3.7.4 Strategic Initiatives
- 8.3.8 The Surgical Company Ptm
- 8.3.8.1 Company Overview
- 8.3.8.2 Financial Performance
- 8.3.8.3 Product Benchmarking
- 8.3.8.4 Strategic Initiatives
- 8.3.9 Life Warmer
- 8.3.9.1 Company Overview
- 8.3.9.2 Financial Performance
- 8.3.9.3 Product Benchmarking
- 8.3.9.4 Strategic Initiatives
- 8.3.10 Mequ
- 8.3.10.1 Company Overview
- 8.3.10.2 Financial Performance
- 8.3.10.3 Product Benchmarking
- 8.3.10.4 Strategic Initiatives
- 8.3.11 Estill Medical Technologies, Inc.
- 8.3.11.1 Company Overview
- 8.3.11.2 Financial Performance
- 8.3.11.3 Product Benchmarking
- 8.3.11.4 Strategic Initiatives
- 8.3.12 Smisson-Cartledge Biomedical
- 8.3.12.1 Company Overview
- 8.3.12.2 Financial Performance
- 8.3.12.3 Product Benchmarking
- 8.3.12.4 Strategic Initiatives